XAGRID

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug XAGRID contains one active pharmaceutical ingredient (API):

1 Anagrelide
UNII VNS4435G39 - ANAGRELIDE HYDROCHLORIDE ANHYDROUS

Anagrelide is an inhibitor of cyclic AMP phosphodiesterase III and suppress expression of transcription factors including GATA-1 and FOG-1 required for megakaryocytopoiesis, ultimately leading to reduced platelet production.

Read about Anagrelide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
XAGRID Capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01XX35 Anagrelide L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX35

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 04164572, 06909958, 14293388, 14336873, 14399052, 15193387, 15609209
Country: EE Ravimiamet Identifier(s): 1208359
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 04295001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 021999
Country: FR Base de données publique des médicaments Identifier(s): 64599534
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 369083, 375384, 381761, 90406
Country: IE Health Products Regulatory Authority Identifier(s): 88375
Country: IT Agenzia del Farmaco Identifier(s): 036745014
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1031388
Country: NL Z-Index G-Standaard, PRK Identifier(s): 77526
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100313581
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68329001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.